Performant Healthcare INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

Performant Healthcare Inc. director Eric Yanagi reports the disposition of shares and restricted stock units on October 21, 2025, due to the company's acquisition by Continental Buyer, Inc. for $7.75 per share.
Performant Healthcare Inc. Director William Dean Hansen disposed of all common stock and restricted stock units as the company completed its merger with Continental Buyer, Inc. for $7.75 per share.
Performant Healthcare Director Lisa Im disposed of all her shares following the company's merger into a wholly-owned subsidiary of Continental Buyer, Inc., receiving $7.75 per share.
Performant Healthcare Inc. CEO Simeon Kohl reports the conversion of common stock and restricted stock units into cash following the company's merger with Continental Buyer, Inc.
Director James LaCamp reports the disposition of all Performant Healthcare shares and restricted stock units due to the company's merger with Continental Buyer, Inc. at $7.75 per share.
Performant Healthcare Inc. Chief Financial Officer Rohit Ramchandani converted all his equity holdings into cash following the company's merger with Continental Buyer, Inc.
A director of Performant Healthcare Inc. disposed of all common stock and restricted stock units following the company's merger into a subsidiary of Continental Buyer, Inc. for $7.75 per share.
Performant Healthcare Inc. director Bradley M. Fluegel's common stock and restricted stock units were converted to cash at $7.75 per share due to the company's merger with Continental Buyer, Inc.
Performant Healthcare CEO Simeon Kohl exercised performance-based Restricted Stock Units and sold shares to cover tax obligations.
Performant Healthcare's CFO, Rohit Ramchandani, acquired shares from RSU vesting and sold a portion for tax liabilities under a Rule 10b5-1 plan.
Performant Healthcare CEO Simeon Kohl acquired 20,250 shares from RSU vesting and sold 7,908 shares for tax obligations.
Performant Healthcare's CFO, Rohit Ramchandani, exercised Restricted Stock Units and sold a portion to cover tax liabilities.
Performant Healthcare CEO Simeon Kohl reported the vesting of Restricted Stock Units and subsequent share transactions, including a sale for tax liability, under a Rule 10b5-1 plan.
Performant Healthcare CFO Rohit Ramchandani acquired shares from RSU vesting and sold a portion for tax obligations, revealing performance-based equity incentives.
Performant Healthcare CEO Simeon Kohl reported the acquisition of common stock through RSU vesting and the sale of shares to cover tax liabilities.
Performant Healthcare's CFO, Rohit Ramchandani, reported planned acquisitions of common stock from RSU vesting and subsequent dispositions for tax liabilities.
Performant Healthcare Director Eric Yanagi reported the acquisition of 35,616 restricted stock units as compensation and disclosed significant indirect beneficial ownership of 3,261,675 common shares through an affiliated fund.
Performant Healthcare Inc. Director Bradley M. Fluegel was granted 35,616 Restricted Stock Units, vesting on the earlier of the 2026 annual meeting or a Change in Control.
Performant Healthcare Inc. Director Shantanu Agrawal received an award of 35,616 restricted stock units, aligning his interests with shareholder value.
Performant Healthcare Inc. Director James LaCamp was granted 35,616 restricted stock units, vesting fully by the 2026 annual meeting or a change in control.
Performant Healthcare Inc. Director William Dean Hansen received an award of 35,616 restricted stock units, granted on July 28, 2025, which will vest in 2026 or upon a change in control.
Lisa Im, a Director at Performant Healthcare Inc., has reported the sale of 180,867 shares of common stock for approximately $587,818, executed under a Rule 10b5-1 trading plan.
Rohit Ramchandani, CFO of Performant Healthcare Inc, reports the vesting and subsequent tax withholding of restricted stock units.
CEO Simeon Kohl reports the vesting of restricted stock units and subsequent tax liability fulfillment through share surrender.
Simeon Kohl, CEO of Performant Healthcare, received two restricted stock unit awards on May 1, 2025, with vesting conditions tied to service and stock price performance.
Rohit Ramchandani, CFO of Performant Healthcare Inc., received two grants of restricted stock units (RSUs) on May 1, 2025, with vesting conditions tied to continued service and stock price hurdles.
Lisa Im, a director at Performant Healthcare, sold 6,154 shares of common stock at an average price of $3.2584 per share.
CEO Simeon Kohl reports the vesting and subsequent tax withholding of shares related to restricted stock units.
Chief Financial Officer Rohit Ramchandani reports the vesting and subsequent tax-related disposal of Performant Financial Corp stock units.
CEO of Performant Financial Corp, Simeon Kohl, was granted restricted stock units on August 5, 2024, subject to service and performance-based vesting conditions.